Literature DB >> 24009179

Fully automated analysis of chemically induced γH2AX foci in human peripheral blood mononuclear cells by indirect immunofluorescence.

Annika Willitzki1, Sebastian Lorenz, Rico Hiemann, Karina Guttek, Alexander Goihl, Roland Hartig, Karsten Conrad, Eugen Feist, Ulrich Sack, Peter Schierack, Lisa Heiserich, Caroline Eberle, Vanessa Peters, Dirk Roggenbuck, Dirk Reinhold.   

Abstract

Analysis of phosphorylated histone protein H2AXH2AX) foci is currently the most sensitive method to detect DNA double-strand breaks (DSB). This protein modification has the potential to become an individual biomarker of cellular stress, especially in the diagnosis and monitoring of neoplastic diseases. To make γH2AX foci analysis available as a routine screening method, different software approaches for automated immunofluorescence pattern evaluation have recently been developed. In this study, we used novel pattern recognition algorithms on the AKLIDES® platform to automatically analyze immunofluorescence images of γH2AX foci and compared the results with visual assessments. Dose- and time-dependent γH2AX foci formation was investigated in human peripheral blood mononuclear cells (PBMCs) treated with the chemotherapeutic drug etoposide (ETP). Moreover, the AKLIDES system was used to analyze the impact of different immunomodulatory reagents on γH2AX foci formation in PBMCs. Apart from γH2AX foci counting the use of novel pattern recognition algorithms allowed the measurement of their fluorescence intensity and size, as well as the analysis of overlapping γH2AX foci. The comparison of automated and manual foci quantification showed overall a good correlation. After ETP exposure, a clear dose-dependent increase of γH2AX foci formation was evident using the AKLIDES as well as Western blot analysis. Kinetic experiments on PBMCs incubated with 5 μM ETP demonstrated a peak in γH2AX foci formation after 4 to 8 h, while a removal of ETP resulted in a strong reduction of γH2AX foci after 1 to 4 h. In summary, this study demonstrated that the AKLIDES system can be used as an efficient automatic screening tool for γH2AX foci analysis by providing new evaluation features and facilitating the identification of drugs which induce or modulate DNA damage.
© 2013 International Society for Advancement of Cytometry.

Entities:  

Keywords:  DNA double-strand breaks; automated microscopy; etoposide; human PBMCs; image analysis; γH2AX foci

Mesh:

Substances:

Year:  2013        PMID: 24009179     DOI: 10.1002/cyto.a.22350

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  11 in total

1.  Mobile phone radiofrequency exposure has no effect on DNA double strand breaks (DSB) in human lymphocytes.

Authors:  Elisa Danese; Giuseppe Lippi; Ruggero Buonocore; Marco Benati; Chiara Bovo; Chiara Bonaguri; Gian Luca Salvagno; Giorgio Brocco; Dirk Roggenbuck; Martina Montagnana
Journal:  Ann Transl Med       Date:  2017-07

2.  Analysis of DNA Double-Strand Breaks and Cytotoxicity after 7 Tesla Magnetic Resonance Imaging of Isolated Human Lymphocytes.

Authors:  Annika Reddig; Mahsa Fatahi; Björn Friebe; Karina Guttek; Roland Hartig; Frank Godenschweger; Dirk Roggenbuck; Jens Ricke; Dirk Reinhold; Oliver Speck
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

3.  Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX.

Authors:  Jana Kroeber; Barbara Wenger; Manuela Schwegler; Christoph Daniel; Manfred Schmidt; Cholpon S Djuzenova; Bülent Polat; Michael Flentje; Rainer Fietkau; Luitpold V Distel
Journal:  Radiat Oncol       Date:  2015-02-11       Impact factor: 3.481

4.  Predicting DNA damage foci and their experimental readout with 2D microscopy: a unified approach applied to photon and neutron exposures.

Authors:  Sofia Barbieri; Gabriele Babini; Jacopo Morini; Werner Friedland; Manuela Buonanno; Veljko Grilj; David J Brenner; Andrea Ottolenghi; Giorgio Baiocco
Journal:  Sci Rep       Date:  2019-09-30       Impact factor: 4.379

5.  LEDGF/p75 Is Required for an Efficient DNA Damage Response.

Authors:  Victoria Liedtke; Christian Schröder; Dirk Roggenbuck; Romano Weiss; Ralf Stohwasser; Peter Schierack; Stefan Rödiger; Lysann Schenk
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

6.  Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.

Authors:  Ludwig Rasche; Lisa Heiserich; Janina Ruth Behrens; Klaus Lenz; Catherina Pfuhl; Katharina Wakonig; René Markus Gieß; Erik Freitag; Caroline Eberle; Jens Wuerfel; Jan Dörr; Peter Bauer; Judith Bellmann-Strobl; Friedemann Paul; Dirk Roggenbuck; Klemens Ruprecht
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

7.  Quantification of damage due to low-dose radiation exposure in mice: construction and application of a biodosimetric model using mRNA indicators in circulating white blood cells.

Authors:  Hiroshi Ishihara; Izumi Tanaka; Haruko Yakumaru; Mika Tanaka; Kazuko Yokochi; Kumiko Fukutsu; Katsushi Tajima; Mayumi Nishimura; Yoshiya Shimada; Makoto Akashi
Journal:  J Radiat Res       Date:  2015-11-19       Impact factor: 2.724

Review 8.  Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Authors:  Mandy Sowa; Rico Hiemann; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

9.  Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors.

Authors:  Treewut Rassamegevanon; Steffen Löck; Michael Baumann; Mechthild Krause; Cläre von Neubeck
Journal:  Int J Mol Sci       Date:  2018-09-04       Impact factor: 5.923

10.  The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes.

Authors:  Björn Friebe; Frank Godenschweger; Mahsa Fatahi; Oliver Speck; Dirk Roggenbuck; Dirk Reinhold; Annika Reddig
Journal:  Eur Radiol Exp       Date:  2018-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.